Literature DB >> 2744050

Systemic bacillus Calmette-Guérin infection, 'BCGitis', in patients treated by intravesical bacillus Calmette-Guérin therapy for bladder cancer.

A Steg1, C Leleu, B Debré, L Boccon-Gibod, D Sicard.   

Abstract

Among 169 patients treated for supeficial bladder tumor with 150 mg Pasteur-strain bacillus Calmette-Guérin (BCG) intravesical instillation, 5 cases of 'BCGitis' were observed, i.e. a severe systemic BCG infection with bronchopulmonary lesions and granulomatous hepatitis. In 4 cases, the complications appeared at the early stage of treatment (after the 3rd, 6th, 6th and 8th instillations, respectively). In 1 case, treated with monthly maintenance therapy for 2 years, BCGitis appeared 6 months after treatment had been completed and, in addition to pulmonary basal infiltrate and granulomatous hepatitis, intramedullary granulomatosis was observed. In 3 patients, trauma must be taken into consideration as BCGitis appeared after traumatic instillation with bleeding. All patients were cured by treatment with rifampicin, isoniazid and prednisone.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2744050     DOI: 10.1159/000471561

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  15 in total

1.  A case of Pott's disease with epidural abscess and probable cerebral tuberculoma following Bacillus Calmette-Guérin therapy for superficial bladder cancer.

Authors:  Colin B Josephson; Saleh Al-Azri; Daniel J Smyth; David Haase; B Lynn Johnston
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

2.  [Development and treatment of localized/systemic BCGitis : Retrospective studies in direct comparison to mitomycin C].

Authors:  W-D U Böhm; R Koch; S Wenzel; M P Wirth; M Toma
Journal:  Urologe A       Date:  2018-05       Impact factor: 0.639

3.  Systemic BCG infection in a patient with pancytopaenia and fever 9 years after intravesical BCG administration for bladder cancer.

Authors:  Ine M Westhovens; Marie-Elena Vanden Abeele; Peter E Messiaen; Jeroen Ch van der Hilst
Journal:  BMJ Case Rep       Date:  2016-05-11

4.  Granulomatous hepatitis caused by Bacillus Calmette-Guerin (BCG) infection after BCG bladder instillation.

Authors:  F W Leebeek; R J Ouwendijk; A H Kolk; A Dees; J C Meek; J E Nienhuis; A M Dingemans-Dumas
Journal:  Gut       Date:  1996-04       Impact factor: 23.059

5.  Mycobacterium bovis BCG recA deletion mutant shows increased susceptibility to DNA-damaging agents but wild-type survival in a mouse infection model.

Authors:  P Sander; K G Papavinasasundaram; T Dick; E Stavropoulos; K Ellrott; B Springer; M J Colston; E C Böttger
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

6.  [Sepsis and multiple organ failure after BCG-instillation for bladder cancer].

Authors:  A Elmer; U Bermes; L Drath; E Büscher; A Viertel
Journal:  Internist (Berl)       Date:  2004-08       Impact factor: 0.743

7.  Mycobacterium bovis spondylodiscitis after intravesical Bacillus Calmette-Guérin therapy.

Authors:  Sami Obaid; Alexander G Weil; Ralph Rahme; Cathy Gendron; Daniel Shedid
Journal:  Surg Neurol Int       Date:  2011-11-14

8.  Bacillus calmette-guerin infection in NADPH oxidase deficiency: defective mycobacterial sequestration and granuloma formation.

Authors:  Christine Deffert; Michela G Schäppi; Jean-Claude Pache; Julien Cachat; Dominique Vesin; Ruth Bisig; Xiaojuan Ma Mulone; Tiina Kelkka; Rikard Holmdahl; Irene Garcia; Maria L Olleros; Karl-Heinz Krause
Journal:  PLoS Pathog       Date:  2014-09-04       Impact factor: 6.823

9.  Peritoneal tuberculosis and granulomatous hepatitis secondary to treatment of bladder cancer with Bacillus Calmette-Guérin.

Authors:  Aliye Soylu; Ali T Ince; Hakan Polat; Nurgul Yasar; Aydin Ciltas; Selvinaz Ozkara; Ali I Tasci
Journal:  Ann Clin Microbiol Antimicrob       Date:  2009-04-15       Impact factor: 3.944

10.  Granulomatous Hepatitis Following Intra-Vesical Instillation of Bacillus Calmette-Guérin for Treatment of Bladder Cancer.

Authors:  Elsa Alves Branco; Raquel Duro; Teresa Brito; António Sarmento
Journal:  Infect Dis Rep       Date:  2021-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.